Equities

Susmed Inc

4263:TYO

Susmed Inc

Actions
  • Price (JPY)553.00
  • Today's Change-11.00 / -1.95%
  • Shares traded32.40k
  • 1 Year change-64.75%
  • Beta--
Data delayed at least 20 minutes, as of Jul 30 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Susmed Inc is a Japan-based company mainly engaged in the digital therapeutics (DTx) development business. The Company operates through two business segments. The DTx Product segment is engaged in the development of application software products for treating diseases such as insomnia, breast cancer, chronic kidney diseases and others. The DTx Platform segment is engaged in the provision of general-purpose clinical trial systems and machine learning automatic analysis systems, as well as the provision of DTx development support services using systems.

  • Revenue in JPY (TTM)340.75m
  • Net income in JPY-358.46m
  • Incorporated2015
  • Employees33.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Tobila Systems Inc2.21bn594.41m8.70bn71.0014.533.9611.073.9456.3156.31208.88206.650.64046.328.0431,065,130.0017.2618.2427.0724.1370.5571.7426.9524.341.96--0.073529.9022.5719.6060.7728.4723.21--
Solxyz Co Ltd15.89bn519.69m8.72bn791.0015.201.099.290.548521.3821.38653.34298.481.3554.776.3420,090,290.004.356.456.309.1423.3323.593.225.322.40--0.103736.1213.573.7333.5438.655.579.86
Densan Co Ltd15.97bn898.61m8.73bn601.009.640.79955.170.5463155.01155.013,003.811,869.930.804262.722.5126,580,110.004.524.286.797.1534.6230.695.635.161.68288.000.311123.58-10.282.55-44.25--23.291.12
Ridge-i Inc943.61m65.65m8.97bn29.00161.034.2599.289.5114.4414.44255.33547.360.4446841.636.0132,538,310.003.09--3.21--70.83--6.96--24.09--0.00---18.39---70.30------
Cyberlinks Co Ltd15.12bn658.00m9.04bn794.0013.631.186.020.598158.2658.261,337.22674.231.1324.033.9819,041,560.004.905.656.807.5231.0929.514.354.591.6155.420.315520.4522.899.18-51.056.7913.9310.20
Monstarlab Holdings Inc12.89bn-2.89bn9.06bn1.43k--2.79--0.7032-83.31-83.31373.2194.770.8914316.883.54---19.73---38.98--22.71---22.13--0.6104--0.6923---6.47---249.06------
APPLIED TECHNOLOGY CO., LTD7.46bn715.82m9.34bn267.0013.031.8512.111.25125.37125.371,307.38882.571.21287.453.0727,957,850.0011.6113.6514.7918.0528.7429.229.5910.344.01--0.0018.364.8617.13-2.7625.96-0.252543.10
Susmed Inc340.75m-358.46m9.45bn33.00--2.00--27.74-21.56-21.5620.47282.530.0664--18.9110,325,700.00-6.98---7.37--96.37---105.20------0.00--67.47--78.26------
Creo Co Ltd14.23bn611.00m9.66bn1.21k14.641.3011.030.678876.8676.861,790.46866.061.4927.046.2611,740,920.006.407.198.729.9322.9423.124.294.623.00132.140.0050.33-2.301.1947.231.55-1.659.86
Future Innovation Group Inc13.12bn296.00m9.76bn718.0032.230.955512.210.74369.629.62430.99324.450.64244.132.4618,274,370.001.481.802.122.5330.6226.852.302.651.6714.160.380558.774.809.49-69.34-5.137.890.00
GRID Inc1.39bn40.00m9.93bn85.00717.902.99122.177.172.932.93274.83702.640.5247--2.1016,296,320.001.52--1.74--70.09--2.89----186.210.026--48.71--148.49------
Japan Data Science Consortium Co Ltd11.62bn-83.83m9.93bn63.00--2.73718.080.8547-6.37-6.37879.74263.891.90--7.30184,419,900.00-1.25---1.69--11.84---0.6557----1.270.3239--37.24--101.56------
tripla Co Ltd1.40bn121.81m9.96bn90.0081.317.5471.567.1121.1021.10241.26227.500.2528--8.3615,571,470.002.23--8.03------8.81--1.2411.970.3682--43.83--121.56------
Mental Health Technologies Co Ltd2.79bn57.88m9.98bn92.00231.459.77100.133.584.264.26266.68101.070.9662472.186.3830,286,890.002.01--2.65--49.81--2.08--1.8016.730.7251--14.00--66.48------
Kayac Inc17.16bn385.70m10.23bn572.0026.761.8412.930.596223.7323.731,058.31345.441.4798.126.8029,996,960.003.756.266.1410.2153.0345.952.544.072.01--0.34210.515.8524.60-34.45---26.8614.29
Data as of Jul 30 2024. Currency figures normalised to Susmed Inc's reporting currency: Japanese Yen JPY

Institutional shareholders

12.12%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 Jan 2024602.20k3.60%
SPARX Asset Management Co., Ltd.as of 31 Jan 2024572.70k3.42%
Asset Management One Co., Ltd.as of 31 Jan 2024425.80k2.54%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 19 Feb 2024209.60k1.25%
Chibagin Asset Management Co. Ltd.as of 30 May 202397.40k0.58%
SBI Asset Management Co., Ltd.as of 22 Jun 202351.00k0.31%
Nikko Asset Management Co., Ltd.as of 20 Jul 202342.60k0.25%
Simplex Asset Management Co., Ltd.as of 04 Jul 202425.30k0.15%
Amundi Japan Ltd.as of 12 Sep 20221.50k0.01%
Norges Bank Investment Managementas of 31 Dec 20230.000.00%
More ▼
Data from 30 May 2023 - 25 Jul 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.